The exchange meeting for biopharmaceutical and venture capital services was successfully held

　　On December 16th, the Wuxi Biomedical Industry Development and Venture Capital Service Matchmaking Exchange Conference was held at the Shangxianhu Fund PARK. The conference was hosted by the Municipal Science and Technology Bureau and Guolian Group, and organized by the Municipal Science and Technology Innovation Center and Wuxi Venture Capital. At this docking and exchange meeting, Xi Venture Capital and its sister companies, Guolian Securities, Huaying Securities, Talent Group, as well as the company's market-oriented team, jointly provided comprehensive solutions for more than 30 biopharmaceutical companies, including early-stage financing for startups, services for companies in the planning stage of going public, and talent services for the biopharmaceutical industry; At the same time, China Merchants Bank is in consultation with enterprises on the "Financial Service Plan for the Pharmaceutical Industry".

　　Hua Xiaofeng, member of the Party Committee and Vice President of Guolian Group, as well as Chairman and President of Xicheng Venture Capital, stated in his speech that Xicheng Venture Capital has always adhered to the investment philosophy of "discovering value, creating value, and enhancing value", working hand in hand with investors, entrepreneurs, and partners to become industry leaders, guardians of entrepreneurship, and industry enablers. Xi Venture Capital has always regarded the operation of the company's municipal angel guidance fund as an important lever for cultivating local brands and supporting innovation and entrepreneurship. At the same time, the company focuses on strengthening the deepening communication and cooperation among enterprises, parks, and peers, working together to provide strategies for the future development of Wuxi's biopharmaceutical industry, promoting and strengthening the deep integration of the industrial chain, innovation chain, and capital chain, exploring new opportunities and models, and jointly building the optimal ecosystem for the development of Wuxi's life medicine and health industry. In the next step, Guolian Group will continue to assist Wuxi's industry in strengthening and supplementing the supply chain, and continue to empower enterprises. The group's subsidiaries, Guolian Securities (Research Institute), Huaying Securities, Talent Group, Guolian Guarantee, Factoring Company, Leasing Company, etc., strive to provide comprehensive services for enterprises from various solutions such as equity funds, debt funds, talent services, and listing services. We strive to make the seeds germinate when they come, bear fruit when they sprout, and achieve fruitful results, contributing to the construction of a trillion level biopharmaceutical industry cluster in Wuxi with the strength of the League of Nations. Wang Zhixing, Co President of Xicheng Venture Capital, gave a detailed introduction to Xicheng Venture Capital's angel investment services from the perspectives of fund business introduction, angel fund ecosystem empowerment, project requirements, etc., with the theme of "direct investment"+"sub fund" dual wheel drive of financial "living water" to nourish innovation and entrepreneurship. Experts from Guolian Securities Research Institute, Huaying Securities, and Talent Group attended the event and delivered keynote speeches. Wuxi Shengya Medical Technology Co., Ltd., Jiangsu Hailai Xinchuang Medical Technology Co., Ltd., and Wuxi Jicheng Biotechnology Co., Ltd. respectively conducted project roadshows on behalf of start-up, IPO, and fundraising companies.